| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |